Hyperemesis Gravidarum (HG) is not self-limiting, and its impact can last a lifetime for mothers and their children. Until there is recognition of this fact and comprehensive, universal, effective treatment for all HG patients, every level of society will continue to face the costs of HG.
Read MoreDr. Marlena Fejzo, HER Research Adviser and Board of Directors, was invited to speak at February’s Keystone Conference on Maternal-Fetal Crosstalk in Santa Fe, NM. Dr. Fejzo presented “Evidence the placenta and appetite hormone GDF15 causes nausea and vomiting of pregnancy” and met with experts on maternal/fetal health from around the world.
Read MoreBe a part of finding answers about Hyperemesis Gravidarum (HG). Currently, the HER Foundation has three active research surveys. Please participate!
Read MoreWhat is the cause of hyperemesis gravidarum? Dr. Fejzo presented our team’s results from the largest ever genetic study of HG (7,197 HG cases and 178,953 controls) at the American Society of Human Genetics annual conference in Los Angeles on October 26, 2022.
Read MoreThe HER Foundation continues the breakthroughs with publication of “Whole-exome sequencing uncovers new variants in GDF15 associated with hyperemesis gravidarum” in BJOG.
Read More2021 has been a busy year for HER research, and we’re finding answers to your questions about Hyperemesis Gravidarum (HG). We’ve had papers published and given presentations. We also have papers under review in scientific journals, abstracts being reviewed for presentation at ACOG, new studies being kicked-off, and we are continuing ongoing research projects.
Read MoreHER Board members, Marlena Fejzo, PhD, and Patrick Mullen, MD, are running the first study of GDF15 in HG patients in the United States.
Read MoreMarlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG).
Read MoreRead the latest research on the safety of ondansetron (Zofran) in an HG pregnancy.
Read More- « Previous
- 1
- 2
- 3
- Next »